Athersys
ATHX
#10697
Rank
C$1.16 M
Marketcap
C$0.01883
Share price
-33.50%
Change (1 day)
-98.93%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -C$56.23 Million

According to Athersys's latest financial reports the company's current earnings are C$0.08 Million. In 2022 the company made an earning of -C$0.11 Billion, an increase over its 2021 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$56.23 Million-47.65%
2022 -C$0.11 Billion-11.54%
2021 -C$0.13 Billion11.14%
2020 -C$0.11 Billion72.2%
2019 -C$63.44 Million77.29%
2018 -C$35.79 Million-22.91%
2017 -C$46.42 Million111.89%
2016 -C$21.91 Million-8.52%
2015 -C$23.95 Million-40.81%
2014 -C$40.47 Million18.62%
2013 -C$34.11 Million
2011 -C$19.22 Million19.71%
2010 -C$16.06 Million-26.28%
2009 -C$21.78 Million-18.21%
2008 -C$26.63 Million-8.28%
2007 -C$29.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.79 B-80,440.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.21 B-24,504.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.51 B-21,593.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.73 B-18,536.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.27 B-53,792.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.00 B-22,436.10%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
C$0.23 B-509.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$3.85 Billion 6,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.88 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA